VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
+$925K
2
LLY icon
Eli Lilly
LLY
+$843K
3
MRNA icon
Moderna
MRNA
+$824K
4
PFE icon
Pfizer
PFE
+$803K
5
MRK icon
Merck
MRK
+$796K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TBPH icon
301
Theravance Biopharma
TBPH
$693M
$246K 0.09%
27,109
-9,250
-25% -$83.9K
CCXI
302
DELISTED
ChemoCentryx, Inc.
CCXI
$246K 0.09%
9,930
-1,284
-11% -$31.8K
OFS icon
303
OFS Capital
OFS
$115M
$245K 0.09%
24,742
-7,755
-24% -$76.8K
ITCI
304
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$245K 0.09%
4,296
-6,123
-59% -$349K
BIIB icon
305
Biogen
BIIB
$21.1B
$244K 0.09%
1,195
-417
-26% -$85.1K
AMGN icon
306
Amgen
AMGN
$151B
$240K 0.09%
985
-755
-43% -$184K
TVTX icon
307
Travere Therapeutics
TVTX
$1.93B
$239K 0.09%
9,875
-4,241
-30% -$103K
MIRM icon
308
Mirum Pharmaceuticals
MIRM
$3.9B
$236K 0.09%
12,137
+976
+9% +$19K
SAGE
309
DELISTED
Sage Therapeutics
SAGE
$235K 0.09%
7,281
-2,313
-24% -$74.7K
HALO icon
310
Halozyme
HALO
$8.9B
$234K 0.09%
5,324
-5,414
-50% -$238K
IRWD icon
311
Ironwood Pharmaceuticals
IRWD
$180M
$234K 0.09%
20,267
-13,795
-40% -$159K
ACAD icon
312
Acadia Pharmaceuticals
ACAD
$4.19B
$201K 0.07%
14,280
-1,892
-12% -$26.6K
KZR icon
313
Kezar Life Sciences
KZR
$29.4M
$182K 0.07%
2,197
+943
+75% +$78.1K
MRSN icon
314
Mersana Therapeutics
MRSN
$38.2M
$161K 0.06%
1,392
+260
+23% +$30.1K
ATRA icon
315
Atara Biotherapeutics
ATRA
$83.9M
$157K 0.06%
804
+409
+104% +$79.9K
PMVP icon
316
PMV Pharmaceuticals
PMVP
$84.8M
$157K 0.06%
10,986
+4,240
+63% +$60.6K
AGEN
317
Agenus
AGEN
$162M
$155K 0.06%
4,064
+1,524
+60% +$58.1K
LYEL icon
318
Lyell Immunopharma
LYEL
$253M
$150K 0.06%
+1,147
New +$150K
BTAI icon
319
BioXcel Therapeutics
BTAI
$52.1M
$149K 0.06%
705
+223
+46% +$47.1K
IOVA icon
320
Iovance Biotherapeutics
IOVA
$858M
$148K 0.05%
13,415
+4,752
+55% +$52.4K
SRNE
321
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$148K 0.05%
73,547
+48,120
+189% +$96.8K
CCCC icon
322
C4 Therapeutics
CCCC
$191M
$145K 0.05%
19,169
+13,894
+263% +$105K
GOSS icon
323
Gossamer Bio
GOSS
$630M
$145K 0.05%
17,370
+2,331
+15% +$19.5K
QURE icon
324
uniQure
QURE
$960M
$144K 0.05%
7,750
+2,237
+41% +$41.6K
IMGN
325
DELISTED
Immunogen Inc
IMGN
$144K 0.05%
32,106
+7,260
+29% +$32.6K